Literature DB >> 18329080

Complications of open radical retropubic prostatectomy in potential candidates for active monitoring.

Stacy Loeb1, Kimberly A Roehl, Brian T Helfand, William J Catalona.   

Abstract

OBJECTIVES: With the widespread use of prostate-specific antigen (PSA)-based screening, there is now concern about the overdiagnosis and overtreatment of men with low-risk prostate cancer (PCa). One of the most difficult aspects of PCa management is a balance of the often-competing goals of cancer control with functional outcomes and quality of life. To address this issue, we examined the potency, continence and overall complication rates associated with radical prostatectomy (RP), specifically in potential candidates for active monitoring.
METHODS: From a large RP database, we compared potency, continence, and complication rates among men meeting one of the following active monitoring criteria from the literature: clinically localized, Gleason score of 7 or less, and no significant comorbidities; T1b-T2b NOMO, Gleason score of 7 or less, and PSA of 15 ng/mL or less; and T1c PCa.
RESULTS: There were 3458, 3533, and 2338 men who met the above criteria, respectively. After 18 months of follow-up, potency was preserved in 70% to 74%. At least 93% of patients were continent, and the rate of surgical complications ranged from 5% to 7%. Increasing age was significantly associated with a greater risk of all complications.
CONCLUSIONS: Men with newly diagnosed low-risk PCa must carefully weigh the risks and benefits of treatment. In young men with low-risk PCa, RP was associated with a relatively low complication rate and good long-term functional outcomes. However, with increasing age, RP was associated with significantly higher complication rates. These results can be used to help guide management decisions for men with low-risk disease.

Entities:  

Mesh:

Year:  2008        PMID: 18329080     DOI: 10.1016/j.urology.2007.12.016

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  Prostate-specific antigen screening can be beneficial to younger and at-risk men.

Authors:  Monique J Roobol; Chris H Bangma; Stacy Loeb
Journal:  CMAJ       Date:  2012-05-07       Impact factor: 8.262

Review 2.  Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.

Authors:  Vinay Prabhu; Ted Lee; Tyler R McClintock; Herbert Lepor
Journal:  Rev Urol       Date:  2013

3.  [The results of the European randomized study of screening for prostate cancer (ERSPC) 2012: confirmation or disappointment?].

Authors:  C Schaefer; L Weissbach
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

4.  An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.

Authors:  Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Henrik Møller; Tim Oliver; Victor Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
Journal:  Mod Pathol       Date:  2010-09-10       Impact factor: 7.842

5.  Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Rebecca Anne Miksad; Kuan-Chi Lai; Thomas Benton Dodson; Sook-Bin Woo; Nathaniel Simon Treister; Omosalewa Akinyemi; Marian Bihrle; Guy Maytal; Meredith August; G Scott Gazelle; J Shannon Swan
Journal:  Oncologist       Date:  2011-01-06

6.  Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.

Authors:  Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Tim Oliver; Henrik Møller; Victor Reuter; Peter Scardino; Jack Cuzick; Daniel M Berney
Journal:  Virchows Arch       Date:  2010-09-09       Impact factor: 4.064

7.  Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols.

Authors:  C Shad Thaxton; Stacy Loeb; Kimberly A Roehl; Donghui Kan; William J Catalona
Journal:  Urology       Date:  2009-12-05       Impact factor: 2.649

Review 8.  Erectile dysfunction following prostatectomy: prevention and treatment.

Authors:  Ahmed Magheli; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

9.  Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models.

Authors:  Christopher Whelan; Mark Kawachi; David D Smith; Jennifer Linehan; Gail Babilonia; Rosa Mejia; Timothy Wilson; Steven S Smith
Journal:  J Urol       Date:  2013-05-10       Impact factor: 7.450

10.  Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance.

Authors:  Jeffrey J Tosoian; Eric JohnBull; Bruce J Trock; Patricia Landis; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; H Ballentine Carter
Journal:  J Urol       Date:  2013-04-30       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.